Skip to product information
1 of 1

MYO7A Recombinant Rabbit mAb (S-2284-21)

MYO7A Recombinant Rabbit mAb (S-2284-21)

Catalog Number: S0B6248 Application: WB,IHC-P,IF Reactivity: Human,Mouse,Rat Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen MYO7A
Synonyms Unconventional myosin-VIIa; USH1B
Immunogen Synthetic Peptide
Location Cytoplasm, Cytoskeleton, Synapse
Accession Q13402
Clone Number S-2284-21
Antibody Type Recombinant mAb
Isotype IgG
Application WB, IHC-P, IF
Reactivity Hu, Ms, Rt
Positive Sample mouse testis, rat testis
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:500-1:1000 Ms, Rt
IHC-P 1:1000 Hu, Ms, Rt
IF 1:500 Hu

Background

MYO7A, encoded by the MYO7A gene, is an unconventional, actin-based molecular motor protein expressed in the inner ear and retina, where it is essential for the development and maintenance of stereocilia in cochlear and vestibular hair cells (critical for mechanotransduction and balance) and for melanosome transport within retinal pigment epithelium (RPE) cells (supporting retinal function). This large protein comprises an N-terminal motor domain, a lever arm with IQ motifs, and a C-terminal tail with MyTH4-FERM domains and an SH3 domain, enabling cargo binding and dimerization to generate processive movement along actin tracks. Mutations in MYO7A cause Usher syndrome type 1B (USH1B), leading to congenital deafness, vestibular dysfunction, and progressive retinitis pigmentosa, as well as nonsyndromic hearing loss (DFNA11 and DFNB2).

Picture

Western Blot

WB result of MYO7A Recombinant Rabbit mAb
Primary antibody: MYO7A Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: mouse brain lysate 20 µg
Lane 2: mouse testis lysate 20 µg
Negative control: mouse brain lysate
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 254 kDa
Observed MW: 260 kDa
This blot was developed with high sensitivity substrate

WB result of MYO7A Recombinant Rabbit mAb
Primary antibody: MYO7A Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: rat brain lysate 20 µg
Lane 2: rat testis lysate 20 µg
Negative control: mouse brain lysate
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 254 kDa
Observed MW: 260 kDa
This blot was developed with high sensitivity substrate

Immunohistochemistry

IHC shows positive staining in paraffin-embedded human kidney. Anti-MYO7A antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded human stomach. Anti-MYO7A antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

Negative control: IHC shows negative staining in paraffin-embedded human cerebral cortex. Anti-MYO7A antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded mouse kidney. Anti-MYO7A antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

Negative control: IHC shows negative staining in paraffin-embedded mouse cerebral cortex. Anti-MYO7A antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

IHC shows positive staining in paraffin-embedded rat kidney. Anti-MYO7A antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

Negative control: IHC shows negative staining in paraffin-embedded rat cerebral cortex. Anti-MYO7A antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

Immunofluorescence

IF shows positive staining in paraffin-embedded human stomach. Anti- MYO7A antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. Counterstained with DAPI (Blue). Heat mediated antigen retrieval with EDTA buffer pH9.0 was performed before commencing with IF staining protocol.

IF shows negative staining in paraffin-embedded human brain. Anti- MYO7A antibody was used at 1/500 dilution and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. Counterstained with DAPI (Blue). Heat mediated antigen retrieval with EDTA buffer pH9.0 was performed before commencing with IF staining protocol.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)